Comparing Belsomra vs Dayvigo
Belsomra (suvorexant) | Dayvigo (lemborexant) |
|
---|
Belsomra (suvorexant) | Dayvigo (lemborexant) |
|
|||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Prescription only
Prescribed for Insomnia. Belsomra may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Insomnia. Dayvigo may also be used for purposes not listed in this medication guide. |
Related suggestions Insomnia
|
|||||||||||||||
More about Belsomra (suvorexant) | More about Dayvigo (lemborexant) | ||||||||||||||||
Ratings & Reviews | |||||||||||||||||
Belsomra has an average rating of 3.9 out of 10 from a total of 542 ratings on Drugs.com. 27% of reviewers reported a positive effect, while 62% reported a negative effect. |
Dayvigo has an average rating of 5.2 out of 10 from a total of 278 ratings on Drugs.com. 43% of reviewers reported a positive effect, while 46% reported a negative effect. |
||||||||||||||||
Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||||||||||
View all Belsomra side effects |
View all Dayvigo side effects |
||||||||||||||||
Drug Class | |||||||||||||||||
Generic Availability | |||||||||||||||||
Pricing and Coupons * Prices are without insurance | |||||||||||||||||
View all Belsomra prices |
View all Dayvigo prices |
||||||||||||||||
Dosage Forms | |||||||||||||||||
|
|
||||||||||||||||
Brand Names | |||||||||||||||||
N/A |
N/A |
||||||||||||||||
Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||||||||||
12 hours |
19 hours |
||||||||||||||||
CSA Schedule 1 View glossary of CSA terms | |||||||||||||||||
Some potential for abuse
Has a low potential for abuse relative to those in schedule 3. It has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 3. |
Some potential for abuse
Has a low potential for abuse relative to those in schedule 3. It has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 3. |
||||||||||||||||
Pregnancy Category | |||||||||||||||||
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
||||||||||||||||
Drug Interactions | |||||||||||||||||
A total of 499 drugs are known to interact with Belsomra:
|
A total of 468 drugs are known to interact with Dayvigo:
|
||||||||||||||||
Alcohol/Food/Lifestyle Interactions | |||||||||||||||||
|
|||||||||||||||||
Disease Interactions | |||||||||||||||||
First Approval Date | |||||||||||||||||
August 13, 2014 |
December 20, 2019 |
||||||||||||||||
WADA Class View classifications | |||||||||||||||||
N/A |
N/A |
||||||||||||||||
More Information | |||||||||||||||||
Patient Resources | |||||||||||||||||
Professional Resources | |||||||||||||||||
Related Treatment Guide | |||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.